Waxman Looking into Waste & Abuse re: Medicare Part D Drug Pricing

Here's part of a statement from the House Oversight Committee:

"Chairman Henry A. Waxman released a new GAO report titled 'Medicare Part D Prescription Drug Coverage: Federal Oversight of Reported Price Concessions Data.' The report finds that the Centers for Medicare & Medicaid Services (CMS) has only conducted half of the scheduled audits of drug pricing information reported by the Part D plans.

“'I’m disappointed by the delay in audits to detect Part D drug pricing fraud,” said Chairman Waxman. 'But the Oversight Committee will continue its investigation of waste and inefficiency in the Part D program to ensure that CMS is taking timely and effective steps to protect taxpayer funds.'”

You can read the GAO report here.